Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson’s Disease: Online-Based Delphi Survey

Figure 2

Summary of the optimal patient type with wearing-off for safinamide. Motor symptoms (Q1): optimal patient based on motor symptoms related to wearing-off; motor complications (Q2): optimal patient type based on motor complications; non-motor symptoms (Q9): optimal patient type based on non-motor symptoms associated with wearing-off. PD : Parkinson’s disease.